United States (US) Bullous Pemphigoid Market (2025-2031) | Share, Value, Growth, Trends, Industry, Forecast, Outlook, Companies, Segmentation, Analysis, Competitive Landscape, Size & Revenue

Name: United States (US) Bullous Pemphigoid Market (2025-2031) | Share & Value
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drugs (Kenketu Glovenin I (Immune globulin), Dupilumab, Efgartigimod PH20 SC, AKST 4290, Ixekizumab, Benralizumab) And Competitive Landscape

Product Code: ETC9961399	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Vasudha	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Bullous Pemphigoid Market Outlook
Market Size of United States (US) Bullous Pemphigoid Market, 2024
Forecast of United States (US) Bullous Pemphigoid Market, 2031
Historical Data and Forecast of United States (US) Bullous Pemphigoid Revenues & Volume for the Period 2021- 2031
United States (US) Bullous Pemphigoid Market Trend Evolution
United States (US) Bullous Pemphigoid Market Drivers and Challenges
United States (US) Bullous Pemphigoid Price Trends
United States (US) Bullous Pemphigoid Porter's Five Forces
United States (US) Bullous Pemphigoid Industry Life Cycle
Historical Data and Forecast of United States (US) Bullous Pemphigoid Market Revenues & Volume By Drugs for the Period 2021- 2031
Historical Data and Forecast of United States (US) Bullous Pemphigoid Market Revenues & Volume By Kenketu Glovenin I (Immune globulin) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Bullous Pemphigoid Market Revenues & Volume By Dupilumab for the Period 2021- 2031
Historical Data and Forecast of United States (US) Bullous Pemphigoid Market Revenues & Volume By Efgartigimod PH20 SC for the Period 2021- 2031
Historical Data and Forecast of United States (US) Bullous Pemphigoid Market Revenues & Volume By AKST 4290 for the Period 2021- 2031
Historical Data and Forecast of United States (US) Bullous Pemphigoid Market Revenues & Volume By Ixekizumab for the Period 2021- 2031
Historical Data and Forecast of United States (US) Bullous Pemphigoid Market Revenues & Volume By Benralizumab for the Period 2021- 2031
United States (US) Bullous Pemphigoid Import Export Trade Statistics
Market Opportunity Assessment By Drugs
United States (US) Bullous Pemphigoid Top Companies Market Share
United States (US) Bullous Pemphigoid Competitive Benchmarking By Technical and Operational Parameters
United States (US) Bullous Pemphigoid Company Profiles
United States (US) Bullous Pemphigoid Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Bullous Pemphigoid Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Bullous Pemphigoid Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Bullous Pemphigoid Market - Industry Life Cycle

3.4 United States (US) Bullous Pemphigoid Market - Porter's Five Forces

3.5 United States (US) Bullous Pemphigoid Market Revenues & Volume Share, By Drugs, 2021 & 2031F

4 United States (US) Bullous Pemphigoid Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of bullous pemphigoid in the US population

4.2.2 Growing awareness and diagnosis rates of bullous pemphigoid

4.2.3 Advancements in treatment options and therapies for bullous pemphigoid patients

4.3 Market Restraints

4.3.1 High cost of treatment for bullous pemphigoid

4.3.2 Limited availability of specialized healthcare professionals for bullous pemphigoid management

4.3.3 Stringent regulatory requirements for approval of new therapies in the bullous pemphigoid market

5 United States (US) Bullous Pemphigoid Market Trends

6 United States (US) Bullous Pemphigoid Market, By Types

6.1 United States (US) Bullous Pemphigoid Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 United States (US) Bullous Pemphigoid Market Revenues & Volume, By Drugs, 2021- 2031F

6.1.3 United States (US) Bullous Pemphigoid Market Revenues & Volume, By Kenketu Glovenin I (Immune globulin), 2021- 2031F

6.1.4 United States (US) Bullous Pemphigoid Market Revenues & Volume, By Dupilumab, 2021- 2031F

6.1.5 United States (US) Bullous Pemphigoid Market Revenues & Volume, By Efgartigimod PH20 SC, 2021- 2031F

6.1.6 United States (US) Bullous Pemphigoid Market Revenues & Volume, By AKST 4290, 2021- 2031F

6.1.7 United States (US) Bullous Pemphigoid Market Revenues & Volume, By Ixekizumab, 2021- 2031F

6.1.8 United States (US) Bullous Pemphigoid Market Revenues & Volume, By Benralizumab, 2021- 2031F

7 United States (US) Bullous Pemphigoid Market Import-Export Trade Statistics

7.1 United States (US) Bullous Pemphigoid Market Export to Major Countries

7.2 United States (US) Bullous Pemphigoid Market Imports from Major Countries

8 United States (US) Bullous Pemphigoid Market Key Performance Indicators

8.1 Patient adherence rates to prescribed treatments

8.2 Average time to diagnosis for bullous pemphigoid patients

8.3 Number of clinical trials investigating new treatment options for bullous pemphigoid

9 United States (US) Bullous Pemphigoid Market - Opportunity Assessment

9.1 United States (US) Bullous Pemphigoid Market Opportunity Assessment, By Drugs, 2021 & 2031F

10 United States (US) Bullous Pemphigoid Market - Competitive Landscape

10.1 United States (US) Bullous Pemphigoid Market Revenue Share, By Companies, 2024

10.2 United States (US) Bullous Pemphigoid Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Bullous Pemphigoid Market

El Salvador Bullous Pemphigoid Market

Equatorial Guinea Bullous Pemphigoid Market

Eritrea Bullous Pemphigoid Market

Estonia Bullous Pemphigoid Market

Ethiopia Bullous Pemphigoid Market

Global Bullous Pemphigoid Market

Middle East Bullous Pemphigoid Market

North America Bullous Pemphigoid Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here